A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
PHASE3CompletedINTERVENTIONAL
Enrollment
439
Participants
Timeline
Start Date
March 31, 2001
Study Completion Date
September 30, 2002
Conditions
Bipolar DisordersManic Disorder
Interventions
DRUG
risperidone
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00253162 - A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol | Biotech Hunter | Biotech Hunter